Phenotyping and genotyping of CYP2C19 using comparative metabolism of proguanil in sickle‐cell disease patients and healthy controls in Nigeria-Reference-Cited by-同舟云学术

Phenotyping and genotyping of CYP2C19 using comparative metabolism of proguanil in sickle‐cell disease patients and healthy controls in Nigeria

Author:

Adejumo Olufunmilayo E.¹²,Kotila Taiwo R.³,Falusi Adeyinka G.⁴,Silva Boladale O.⁵,Nwogu Jacinta N.²,Fasinu Pius S.¹⁶,Babalola Chinedum P.²⁴

Affiliation:

1. Department of Pharmaceutical and Medicinal Chemistry Faculty of Pharmacy Olabisi Onabanjo University Sagamu Nigeria

2. Department of Pharmaceutical Chemistry Faculty of Pharmacy University of Ibadan Ibadan Nigeria

3. Department of Haematology College of Medicine University of Ibadan Ibadan Nigeria

4. Genetic and Bioethics Unit Institute of Advanced Medical Research and Training (IMRAT) College of Medicine University of Ibadan Ibadan Nigeria

5. Department of Pharmaceutics and Pharmaceutical Technology Faculty of Pharmacy University of Lagos Lagos Nigeria

6. National Center for Natural Product Research School of Pharmacy University of Mississippi Oxford Mississippi United States

Funder

University of Ibadan called Senate Research Grant (SRG)

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,Neurology

Link

Reference40 articles.

2. Treatment and prevention of Plasmodium falciparum malaria;Bhatt SM;Afr J Med Pract,1994